(Q31924783)

5 July 2017

title

Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women (English)

1 reference

5 July 2017

1 reference

1 reference

K Erb

1

1 reference

5 July 2017

C Klipping

2

1 reference

5 July 2017

I Duijkers

3

1 reference

5 July 2017

B Pechstein

4

1 reference

5 July 2017

A Schueler

5

1 reference

5 July 2017

R Hermann

6

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

published in

Fertility and Sterility

1 reference

5 July 2017

volume

75

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

316-323

1 reference

Characterization of gonadotropin-releasing hormone analogs based on a sensitive cellular luciferase reporter gene assay

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Gonadotropin-releasing hormone and its analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

LH-RH analogues: I. Their impact on reproductive medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Gonadotropin-releasing hormone antagonist: new tools vs. old habits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901702-7

10.1016/S0015-0282(00)01702-7

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference